Midazolam vs Upadacitinib
Midazolam vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Midazolam and Upadacitinib.
Mechanism of Action
Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Midazolam β 1.5-2.5 hours; Upadacitinib β 9-14 hours.
Chemical Properties
Molecular Formula: Midazolam β C18H13ClFN3; Upadacitinib β C17H19F3N6O.
Molecular Weight: Midazolam β 325.7670 g/mol; Upadacitinib β 380.3700 g/mol.
Type: Midazolam β Small molecule; Upadacitinib β Small molecule.